GIALLONGO, CESARINA
 Distribuzione geografica
Continente #
NA - Nord America 4.340
EU - Europa 2.469
AS - Asia 1.657
AF - Africa 400
SA - Sud America 303
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.176
Nazione #
US - Stati Uniti d'America 4.256
IT - Italia 1.598
SG - Singapore 659
CN - Cina 642
CI - Costa d'Avorio 328
IE - Irlanda 288
BR - Brasile 265
UA - Ucraina 136
KR - Corea 115
DE - Germania 103
VN - Vietnam 63
CA - Canada 61
RU - Federazione Russa 59
FI - Finlandia 51
SN - Senegal 49
IN - India 44
FR - Francia 43
GB - Regno Unito 43
SE - Svezia 34
JP - Giappone 27
CZ - Repubblica Ceca 23
NL - Olanda 21
HK - Hong Kong 19
MX - Messico 17
BE - Belgio 15
BD - Bangladesh 14
CH - Svizzera 13
EC - Ecuador 13
AR - Argentina 11
PL - Polonia 11
LB - Libano 8
UZ - Uzbekistan 8
IL - Israele 7
TR - Turchia 7
AE - Emirati Arabi Uniti 6
ES - Italia 6
NG - Nigeria 6
GR - Grecia 5
IQ - Iraq 5
MA - Marocco 5
AT - Austria 4
AU - Australia 4
ID - Indonesia 4
LT - Lituania 4
PK - Pakistan 4
TN - Tunisia 4
NO - Norvegia 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
SA - Arabia Saudita 3
TH - Thailandia 3
ZA - Sudafrica 3
AL - Albania 2
BO - Bolivia 2
CL - Cile 2
CO - Colombia 2
KZ - Kazakistan 2
PS - Palestinian Territory 2
PT - Portogallo 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
MK - Macedonia 1
NI - Nicaragua 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.176
Città #
Dallas 1.284
Santa Clara 649
Singapore 471
Chandler 453
Catania 442
Abidjan 327
Chicago 287
Dublin 285
Hefei 213
Jacksonville 156
Ashburn 145
Boardman 123
Seoul 115
Beijing 104
Civitanova Marche 91
Florence 85
Houston 74
Cambridge 68
Lawrence 68
Andover 64
Rome 64
Los Angeles 60
Milan 50
Dakar 49
Palermo 45
Dong Ket 44
Munich 43
Nanjing 42
Toronto 38
Des Moines 36
Bronte 26
Misterbianco 26
Bremen 25
Bari 24
Wilmington 24
Messina 23
Council Bluffs 20
The Dalles 20
Brno 19
Helsinki 19
Hong Kong 19
Saint Petersburg 19
San Mateo 19
Falls Church 18
Nanchang 18
Shenyang 17
Lappeenranta 16
São Paulo 16
Turku 16
Washington 16
Columbus 15
New York 15
Dearborn 14
Fukuoka 14
Paris 14
Brooklyn 13
Brussels 13
Turin 13
Hebei 12
Kochi 12
Tokyo 12
Augusta 11
Ottawa 11
Changsha 10
Hanoi 10
Moscow 10
Naples 10
Seattle 10
Warsaw 10
Aci Catena 9
Guangzhou 9
Jiaxing 9
Acireale 8
Belpasso 8
Boston 8
Chennai 8
Tianjin 8
Genoa 7
Hanover 7
Ragusa 7
San Giovanni la Punta 7
Abuja 6
Amsterdam 6
Curitiba 6
Den Haag 6
Mascalucia 6
Mexico City 6
Modica 6
Rio de Janeiro 6
San Francisco 6
Torino 6
Vicenza 6
Charlotte 5
Floridia 5
Grafing 5
Jinan 5
London 5
Montreal 5
Padova 5
Pozzallo 5
Totale 6.805
Nome #
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 231
Biological properties of Cakile maritima Scop. (Brassicaceae) extracts 178
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload 176
Antimicrobial and anti-proliferative effects of skin mucus derived from dasyatis pastinaca (Linnaeus, 1758) 170
Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells. 154
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 153
Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance 147
Inhibition of TLR4 signaling affects mitochondrial fitness and overcomes bortezomib resistance in myeloma plasma cells 147
Clobetasol promotes neuromuscular plasticity in mice after motoneuronal loss via sonic hedgehog signaling, immunomodulation and metabolic rebalancing 146
Biological properties of itraconazole-SLN 144
Ixazomib improves bone remodeling and counteracts sonic hedgehog signaling inhibition mediated by myeloma cells 142
Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM) 134
Clobetasol modulates adult neural stem cell growth via canonical hedgehog pathway activation 128
Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib 127
A cytoprotective role for the heme oxygenase-1/CO pathway during neural differentiation of human mesenchymal stem cells 124
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis 123
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection 119
Chitinase domain containing 1 increase is associated with low survival rate and M0 macrophages infiltrates in colorectal cancer patients 117
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells. 117
Hedgehog signaling pathways in multiple myeloma 114
Biological properties of itraconazole-SLNs 113
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases 112
Focus on Osteosclerotic Progression in Primary Myelofibrosis 112
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells 109
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis 108
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling 106
BORTEZOMIB INHIBITS OSTEOCLASTOGENESIS AND MODULATE CHIT1 AND YKL40 EXPRESSION 105
Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential 105
Lactate Rewrites the Metabolic Reprogramming of Uveal Melanoma Cells and Induces Quiescence Phenotype 104
Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 104
Effect of lipoic acid on the biochemical mechanisms of resistance to bortezomib in SH-SY5Y neuroblastoma cells 103
Bortezomib Inhibits Osteoclastogenesis and Bone Resorption Through Modulation of CHIT1 and YKL40 Expression 103
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib 103
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 102
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 101
Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma 101
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 97
Lactate Induces the Expressions of MCT1 and HCAR1 to Promote Tumor Growth and Progression in Glioblastoma 97
Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells 96
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma 96
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation 95
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 94
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy 93
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients 92
Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors 90
CIRCULATING ARGINASE-1 IN SERUM IS A NOVEL BIO-MARKERIN HODGKIN LYMPHOMA 90
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells 90
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma (Cell Death & Disease, (2019), 10, 10, (704), 10.1038/s41419-019-1959-5) 89
Role of 17β-Estradiol on Cell Proliferation and Mitochondrial Fitness in Glioblastoma Cells 89
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint. 87
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 85
Correction to: Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models (Antioxidants, (2022), 11, 8, (1596), 10.3390/antiox11081596) 84
The Role of Epigenetics in Neuroinflammatory-Driven Diseases 83
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint 83
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients 82
The Heme Oxygenase System in Hematological Malignancies 81
Effects of imatinib mesylate in osteoblastogenesis 80
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 80
Pericytes in microvessels: From “mural” function to brain and retina regeneration 80
Electronic nicotine delivery systems exhibit reduced bronchial epithelial cells toxicity compared to cigarette: the Replica Project 80
Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models 78
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers 76
Myeloid-derived suppressor cells in Chronic myeloid leukemia 75
Nuclear translocation of Heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells 74
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview 74
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future 73
Modulation of extracellular signal-related kinase, cyclin D1, glial fibrillary acidic protein, and vimentin expression in estradiol-pretreated astrocyte cultures treated with competence and progression growth factors 73
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia 73
Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment 72
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes 72
Neuroactive molecules and growth factors modulate cytoskeletal protein expression during astroglial cell proliferation and differentiation in culture 72
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience 71
MONOCYTIC MYELOID DERIVED SUPPRESSOR CELLS (M-MDSC) AS PROGNOSTIC FACTOR IN DASATINIB TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA 71
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis 69
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting 68
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment 65
GRANULOCYTE-LIKE MYELOID DERIVED SUPPRESSOR CELLS ARE INCREASED IN MULTIPLE MYELOMA DUE TO IMMUNOLOGICAL DYSREGULATION OF MESENCHYMAL STEM CELLS 64
OVEREXPRESSION OF ARGINASE AND PROK-2 MAKES NEUTROPHILS OF MULTIPLE MYELOMA DYSFUNCTIONAL AND IMMUNOSUPPRESSIVE 63
Correction to: Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 62
Immunoproteasome Genes Are Modulated in CD34+ JAK2V617F Mutated Cells from Primary Myelofibrosis Patients 61
Ixazomib inhibits osteoclastogenesis and promotes osteogenic differentiation in vitro 59
IMPAIRED NEUTROPHIL FUNCTION IN PATIENTS WITH ACUTE LEUKEMIA 59
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma. 59
Targeted metabolomic evaluation of peripheral blood mononucleated cells from patients with PMM2-CDG 57
Proteasome inhibitors as a possible therapy for SARS-CoV-2 56
LENALIDOMIDE TREATMENT IS ABLE TO RESTORE REGULATORY T CELLS IN MULTIPLE MYELOMA PATIENTS 55
Monocytic myeloid derived suppressor cells in hematological malignancies 55
Pituitary Adenylate Cyclase-Activating Polypeptide Protects Corneal Epithelial Cells against UV-B-Induced Apoptosis via ROS/JNK Pathway Inhibition 55
Uveal melanoma cells elicit retinal pericyte phenotypical and biochemical changes in an in vitro model of coculture 54
IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis 54
MESENCHYMAL STEM CELLS FROM CML PATIENTS REGULATE MYELOID DERIVED SUPPRESSOR CELLS ACTIVATION 53
Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome 53
The Role of Inflammation and Inflammasome in Myeloproliferative Disease 53
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells 52
Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients 52
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors 51
The Pleiotropic Effects of Fumarate: From Mitochondrial Respiration to Epigenetic Rewiring and DNA Repair Mechanisms 50
IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis 50
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC) 49
Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation. 48
Totale 9.175
Categoria #
all - tutte 32.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.894


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021393 0 0 0 32 111 16 61 11 30 7 49 76
2021/2022653 41 77 10 4 116 26 101 49 51 31 18 129
2022/20231.368 96 112 40 144 111 188 19 237 267 44 71 39
2023/2024928 55 140 39 40 47 203 40 88 4 25 168 79
2024/20252.886 42 456 155 198 522 357 157 136 175 226 242 220
2025/20262.415 417 883 1.051 64 0 0 0 0 0 0 0 0
Totale 9.379